HIGHFDA DEVICE

Argon Medical Devices Recalls 1,821 Option Elite IVC Filters for Dilator Resistance Risk (2025)

Argon Medical Devices recalled 1,821 Option Elite Vena Cava Filter System devices sold to U.S. hospitals and international distributors. The recall cites a dilator resistance issue within the introducer sheath that could slow procedures and injure venous tissue. Healthcare providers and patients should stop using the device immediately and follow the recall instructions.

Official notice
Argon Medical DevicesHealth & Personal CareMedical Devices352506070E (UDI-DI 00886333217151) Lot numbers: 11633166, 11633125, 11629543, 11629273, 11628836

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
September 12, 2025
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
September 12, 2025
Hazard Level
HIGH
Brand
Argon Medical Devices
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Argon Medical Devices
Product type
Inferior Vena Cava Filter System
Model numbers
352506070E (UDI-DI 00886333217151) Lot numbers: 11633166, 11633125, 11629543, 11629273, 11628836
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 12, 2025

  2. Reported by FDA DEVICE

    December 3, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Due to complaints of increased resistance when advancing the dilator within the introducer sheath. This issue could potential result in procedural delays and/or risk of venous intimal injuries if excessive force is applied

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Argon Medical Devices, Inc or your healthcare provider for instructions. Notification method: Letter

About This Product

The Option Elite Vena Cava Filter System is used to prevent recurrent pulmonary embolism by placing a filter in the inferior vena cava. It is intended for percutaneous placement and is distributed to U.S. hospitals and international distributors.

Why This Is Dangerous

A defect causes increased resistance when advancing the dilator inside the introducer sheath. This can delay procedures and risk venous injury if excessive force is applied.

Industry Context

This recall is not described as part of a broader industry pattern in the provided data.

Real-World Impact

Hospitals must stop using the device and coordinate with Argon and clinicians for guidance. The recall affects 1,821 devices and may lead to delays in procedures and potential patient safety concerns if the devices are used.

Practical Guidance

How to identify if yours is affected

  1. Confirm device is Option Elite Vena Cava Filter System (REF 352506070E)

Where to find product info

Device labeling, packaging, and recall communications from Argon Medical Devices or the FDA recall page

What timeline to expect

Refund or replacement typically takes 4-6 weeks after submission of claim

If the manufacturer is unresponsive

  • Escalate to hospital compliance department
  • File a complaint with FDA if manufacturer is unresponsive
  • Keep documentation of all communications and recalls

How to prevent similar issues

  • Check recall notices for all implanted devices
  • Use only approved distributors and hospital procurement channels
  • Verify model, UDI-DI, and lot numbers before use or implantation

Documentation advice

Keep photos of device labeling, retain all recall notices, document communications with healthcare providers and manufacturers

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model Number: 352506070E UDI-DI: 00886333217151 Lot Numbers: 11633166, 11633125, 11629543, 11629273, 11628836 Total Quantity: 1821 units (US 1794; OUS 27) Sold to: U.S. hospitals nationwide; international distribution to China, Panama and Trinidad and Tobago Recall Date: 2025-09-12 Status: ACTIVE Manufacturer: Argon Medical Devices Category: Health & Personal Care, Medical Devices Price: Unknown

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 1,821 total units recalled (US 1,794; OUS 27)
  • Model 352506070E, UDI-DI 00886333217151
  • Recall date 2025-09-12; status ACTIVE
  • Hazard: increased resistance during dilator advancement within the introducer sheath
  • No injuries or incidents reported

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
LACERATIONOTHER

Product Details

Model Numbers
352506070E (UDI-DI 00886333217151) Lot numbers: 11633166, 11633125, 11629543, 11629273, 11628836
Affected States
ALL
Report Date
December 3, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more